Immunomodulation by LongoVital in patients with recurrent aphthous ulceration

A Pedersen, B Klausen, H P Hougen, L Ryder, K Winther

14 Citations (Scopus)

Abstract

LongoVital (LV) (DK. Reg. No. 5178/75) is a herbal based tablet enriched with recommended doses of vitamins. Peripheral lymphocyte subsets: T-helper/CD4 (OKT4+) and T-suppressor/cytotoxic/CD8 (OKT8+) were studied quantitatively in 31 otherwise healthy patients with minor recurrent aphthous ulceration (RAU) during 6 months' daily LV intake in a double-blind, randomized, crossover 1-year study. Fourteen had had LV during the first 6 months (GrA) and 17 LV during the latter 6 months (GrB). OKT4+ percentages increased significantly during the LV period in both groups (P less than 0.05). OKT8+ percentages increased in both groups, however, only significantly in GrA (P less than 0.05). It is concluded that LV acts as an immunostimulator in patients with RAU and that the increase in T-lymphocyte subsets may account for the previously reported benefit of LV in RAU prevention.
Original languageEnglish
JournalJournal of Oral Pathology & Medicine
Volume19
Issue number8
Pages (from-to)376-80
Number of pages5
ISSN0904-2512
Publication statusPublished - 1990

Keywords

  • Adult
  • Aged
  • Analysis of Variance
  • CD4-Positive T-Lymphocytes
  • Double-Blind Method
  • Female
  • Humans
  • Killer Cells, Natural
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Phytotherapy
  • Recurrence
  • Stomatitis, Aphthous
  • T-Lymphocytes, Helper-Inducer
  • T-Lymphocytes, Regulatory
  • Ulcer

Fingerprint

Dive into the research topics of 'Immunomodulation by LongoVital in patients with recurrent aphthous ulceration'. Together they form a unique fingerprint.

Cite this